Conecte-se

Bibliografias temáticas / Biotechnology / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Biotechnology.

Artigos de revistas sobre o tema "Biotechnology"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 28 de setembro de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Biotechnology".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Yaseen, Arshed H., Halah M. H. Al-Hasani e Umer Abdullah Ahmed Alelyan. "Biotechnology for medical diagnosis". Drug and Pharmaceutical Science Archives 02, n.º 01 (2022): 01–05. http://dx.doi.org/10.47587/dpsa.2022.2101.

Texto completo da fonte

Resumo:

Biotechnology is broadly defined as, “using organisms or their products for commercial purposes” encompasses a wide range. Since the beginning of time, people have used (traditional) biotechnology. Wheat, brew alcohol, and breed food crops and domestic animals have all been made using this grain. Molecular biology’s most recent breakthroughs, on the other hand, have given new life to biotechnology’s relevance and potential. Biotechnology has become a hot topic among the general public. There’s a good chance that modern biotechnology will have a big impact on the environment. Small-molecule (chemical) medications produced by well-known pharmaceutical companies have traditionally accounted for the vast majority of human illness treatments. The current article discussed.

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Adeyinka, Olawale Samuel, Oghenerobor Benjamin Akpor e Abimbola Pius Okiki. "Untapped potentials of Agricultural Biotechnology in Nigeria". Journal of Bioscience and Biotechnology Discovery 6, n.º 4 (30 de outubro de 2021): 33–37. http://dx.doi.org/10.31248/jbbd2021.152.

Texto completo da fonte

Resumo:

The field of biotechnology has witnessed a significant achievement over the past decades. Although biotechnology always sparked a great deal of ethical criticism, the advancement has continued to offer an opportunity to address several social and economic challenges. The potentials of biotechnology remain underexploited in several fields in Nigeria. This review highlighted some untapped biotechnologies that represent an ample scope of biotechnology application used for the genetic improvement of plant and animal populations, conservation of genetic resources, and diagnosis of plant and animal diseases. Factors such as insufficient of funds to procure facilities, inadequate power supply, lack of sufficient trained manpower, lack of political will to support biotechnology has been limiting biotechnology's potentials in Nigeria. Therefore, it was recommended that attention should be given to biotechnology research and development to complement existing expertise in the national biotechnology sector towards maximizing its potentials.

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Sahu, Jyoti. "Future aspects of biotechnology and biological science in India". Journal of Medical Pharmaceutical and Allied Sciences 2, n.º 1 (fevereiro de 2013): 33–37. http://dx.doi.org/10.55522/jmpas.v2i1.0007.

Texto completo da fonte

Resumo:

Everybody wants to enter a field which is hot one such field is biotechnolog, Biotechnology has prcious scope, Its new and booming field and most important there is less saturation. Biotechnology is the offshoot of science in which livings being are used for production. Students, who have keen interest in Biotechnology and want to make their bright future in this field, have a lot of career opportunities in this field. Scientists, Pharmacists, Biomedical engineer, Medical scientists, Lecturer, Patent agents, Patent lawyer etc. Biotechnology is an interdisciplinary Science; it is like a growing tree. About a dozen of specialization branches of science like Biochemistry, Molecular biology, Cell biology, Bioinformatics, Chemical engineering, Food science, material science and so an these are the root of biotechnologynological tree, and animal health, Vaccine, Crop yields, Environmental monitoring, pollution control, Therapeutics are the applications of this branch. The term biotechnology was introduced by Karl Ereky in 1917. He used the term for large scale culture of pigs by the use of sugar beets the source of food material.. As biotechnology is a subject with lot of promises, students are getting attracted to this stream of science and with India emerging as one of the biggest leader in biotechnology.

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Boulay, Jean-Louis, e Sylvie Miot. "Chemical biotechnology Pharmaceutical biotechnology". Current Opinion in Biotechnology 11, n.º 6 (dezembro de 2000): 515. http://dx.doi.org/10.1016/s0958-1669(00)00138-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Boulay, Jean-Louis. "Pharmaceutical biotechnology: Chemical biotechnology". Current Opinion in Biotechnology 10, n.º 6 (dezembro de 1999): 523–24. http://dx.doi.org/10.1016/s0958-1669(99)00022-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Verjan García, Noel. "Biotechnology, powerful tools for research and development". Orinoquia 13, n.º 1 (1 de janeiro de 2009): 2. http://dx.doi.org/10.22579/20112629.217.

Texto completo da fonte

Resumo:

ABSTRACT: The concept of biotechnology has been in the human mind since very ancient times, when the first human beings discovered the production of wine by fermenting fruit juices, the brewing beer industry, and the conversion of milk into cheese or yogurt. However, as these basic processes have going through a wide range of developments to supply specific requirements, biotechnology has evolved and some of its most dramatic advances were observed during in the last 30-years. Modern biotechnology begins with the ability to transfer a specific gene from one organism to another by using a set of genetic engineering techniques, thus recombinant DNA technology sparked an era o biotech revolution. This major achievement, together with the maintenance and growth of genetically uniform plant-and animal cell cultures increased dramatically the spectrum of biotechnology’s applications in disease prevention, treatment and quality of life.

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Zamora-González, Edgar Oswaldo, Angel Herráez, Paula Daniela Gutiérrez-Muñoz, Olivia Torres-Bugarín, María Valentina Toral-Murillo, Benjamín Gómez-Díaz, Cecilia Adriana Calderón-Reyes et al. "Implementation of Biotechnology Applied to Medicine Course Using Virtual Laboratories: Perceptions and Attitudes of Students". Education Sciences 14, n.º 2 (2 de fevereiro de 2024): 157. http://dx.doi.org/10.3390/educsci14020157.

Texto completo da fonte

Resumo:

The rapid evolution of biotechnology across various sectors, including agriculture, industry, and medicine, has profoundly transformed our comprehension of the world. Virtual laboratories (VLs) provide an immersive learning experience that can enhance future generations’ understanding of biotechnology’s medical applications. This study investigated the impact of incorporating VLs into a short course on biotechnology applied to medicine on the attitudes and perceptions of third-year medical students (n = 210). A validated questionnaire was employed to assess their perspectives, attitudes, and experience with virtual laboratory platforms before and after the course. The findings revealed a significant positive change in 7/38 questionnaire items (p < 0.05), indicating that the VL experience modified perceptions about biotechnology. This study emphasizes the importance of exploring innovative teaching methods for biotechnology and highlights the advantages of VL in educating future physicians. The primary concerns of the students were the misuse of personal genetic information and biotechnological applications involving animal modification. Overall, the students had a favorable experience using the virtual laboratory platforms. These findings collectively suggest that VL can positively influence perceptions and attitudes toward biotechnology among healthcare professionals.

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Gábor, Miklós Gábor, e Ubul Pál Kralovánszky. "The father of the term ‘biotechnology’ was Hungarian: The forgotten works of Károly Ereky". Acta Agraria Debreceniensis, n.º 17 (14 de setembro de 2005): 107–10. http://dx.doi.org/10.34101/actaagrar/17/3279.

Texto completo da fonte

Resumo:

In the Nature, Robert Bud gave an account of the fact that the generator of the concept "biotechnology" was the Hungarian Karl Ereky who, in his book published in Berlin in 1919 entitled "Biotechnologie der Fleisch-, Fett- und Milcherzeugung im landwirtschaftlichen Grossbetriebe" ("Biotechnology of Meat, Fat and Milk Production in a Large-Scale Agricultural Farm"), disclosed his observations and new views in that regard. Later on, Ereky's two essays, published in German language again, and other contemporary German sources have been processed which have confirmed the assumption whereas – in scientific terms – the further first applications of the expression "biotechnology" can be attributed to Ereky's works. Recently, we have explored and found biographical sources and documents which had been published by Ereky, which, however, have already been forgotten, by dint of which the story of origin of the first concept "biotechnology" can as well be clarified in a factual manner.

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Birkinshaw, Julian, Ivanka Visnjic e Simon Best. "Responding to a Potentially Disruptive Technology: How Big Pharma Embraced Biotechnology". California Management Review 60, n.º 4 (5 de junho de 2018): 74–100. http://dx.doi.org/10.1177/0008125618778852.

Texto completo da fonte

Resumo:

How do incumbent firms respond over time to a potentially disruptive technology? This article documents the strategies of 12 large pharmaceutical firms over 25 years as they addressed the opportunity/threat of biotechnology. All showed awareness of biotechnology’s potential, but their response profiles varied dramatically in terms of timing (early/late) and focus (external/internal). Late movers mostly made large acquisitions to “catch up,” but early movers maintained their lead in terms of biotechnology-based drug sales and profitability, and those with a more “open” response profile performed better. This response involves a three-step process: building awareness (sensing), building capability (responding), and building commitment (scaling).

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Sapozhnikova, Alla Sapozhnikova, e Elena Pekhtasheva. "Collagen Applications in Biotechnology". Indian Journal of Applied Research 4, n.º 5 (1 de outubro de 2011): 625–27. http://dx.doi.org/10.15373/2249555x/may2014/197.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Silpa, S. "Nanotechnology-Present Revolutionary Biotechnology". International Journal of Pharma Research and Health Sciences 4, n.º 4 (2016): 1261–67. http://dx.doi.org/10.21276/ijprhs.2016.04.03.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Klyuchko, O. M. "CLUSTER ANALYSIS IN BIOTECHNOLOGY". Biotechnologia Acta 10, n.º 5 (outubro de 2017): 5–18. http://dx.doi.org/10.15407/biotech10.05.005.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

TAKATSUJI, Masamoto. "Biotechnology." Journal of the Japan Society for Precision Engineering 54, n.º 1 (1988): 51–52. http://dx.doi.org/10.2493/jjspe.54.51.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Santiago Vispo, Nelson. "Biotechnology". Bionatura 1, n.º 1 (15 de janeiro de 2016): 3. http://dx.doi.org/10.21931/rb/2016.01.01.1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Wickelgren, Ingrid. "Biotechnology". Science News 135, n.º 19 (13 de maio de 1989): 300. http://dx.doi.org/10.2307/3973298.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Sun, Marjorie. "Biotechnology". Science 228, n.º 4705 (14 de junho de 1985): 1294–95. http://dx.doi.org/10.1126/science.228.4705.1294.b.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Sun, Marjorie. "Biotechnology". Science 228, n.º 4705 (14 de junho de 1985): 1294–95. http://dx.doi.org/10.1126/science.228.4705.1294-b.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Mote, Patricia. "Biotechnology". American Biology Teacher 70, n.º 3 (1 de março de 2008): 173–74. http://dx.doi.org/10.2307/30163233.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

KAMAKURA, Takashi, Toshihiro NAGAMINE e Hideo OHKAWA. "BIOTECHNOLOGY". Journal of Pesticide Science 19, Special (1994): S309—S313. http://dx.doi.org/10.1584/jpestics.19.special_s309.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Bennett, Dawn D., e Julie Ann Miller. "Biotechnology". Science News 127, n.º 21 (25 de maio de 1985): 329. http://dx.doi.org/10.2307/3969682.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Morohoshi, Noriyuki. "Biotechnology." JAPAN TAPPI JOURNAL 41, n.º 10 (1987): 983–91. http://dx.doi.org/10.2524/jtappij.41.983.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Evens, Ronald P., e Mark Witcher. "Biotechnology". Therapeutic Drug Monitoring 15, n.º 6 (dezembro de 1993): 514–20. http://dx.doi.org/10.1097/00007691-199312000-00011.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

HARLANDER, SUSAN K. "Biotechnology". Nutrition Today 22, n.º 4 (julho de 1987): 21–29. http://dx.doi.org/10.1097/00017285-198708000-00004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Cole-Turner, Ronald. "Biotechnology". Theology Today 59, n.º 1 (abril de 2002): 39–54. http://dx.doi.org/10.1177/004057360205900104.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz, Michiel Kleerebezem e Steve Projan. "Biotechnology". Current Opinion in Biotechnology 11, n.º 2 (abril de 2000): 109–14. http://dx.doi.org/10.1016/s0958-1669(00)00067-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz e Steve Projan. "Biotechnology". Current Opinion in Biotechnology 11, n.º 3 (junho de 2000): 219–25. http://dx.doi.org/10.1016/s0958-1669(00)00101-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Cass, Tony, Jim Dunwell, Andrew J. Dauglis, Thomas A. Kost, Patrick Condreay e Jeroen Hugenholtz. "Biotechnology". Current Opinion in Biotechnology 11, n.º 4 (agosto de 2000): 309–13. http://dx.doi.org/10.1016/s0958-1669(00)00103-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz e Michiel Kleerebezem. "Biotechnology". Current Opinion in Biotechnology 12, n.º 2 (abril de 2001): 113–19. http://dx.doi.org/10.1016/s0958-1669(00)00182-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Dunwell, Jim, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz e Michiel Kleerebezem. "Biotechnology". Current Opinion in Biotechnology 12, n.º 3 (junho de 2001): 221–26. http://dx.doi.org/10.1016/s0958-1669(00)00203-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz, Nicholas J. Turner e Robert E. Speight. "Biotechnology". Current Opinion in Biotechnology 12, n.º 4 (agosto de 2001): 321–28. http://dx.doi.org/10.1016/s0958-1669(00)00221-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steven Projan et al. "Biotechnology". Current Opinion in Biotechnology 13, n.º 1 (fevereiro de 2002): 1–8. http://dx.doi.org/10.1016/s0958-1669(02)00275-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Dunwell, Jim, Lawrence P. Wackett, Thomas A. Kost, Patrick Condreay, Steven Projan, Jeroen Hugenholtz, Michiel Kleerebezem, Nicholas J. Turner e Robert E. Speight. "Biotechnology". Current Opinion in Biotechnology 13, n.º 2 (abril de 2002): 77–81. http://dx.doi.org/10.1016/s0958-1669(02)00289-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Halliwell, Catherine, Tony Cass, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay et al. "Biotechnology". Current Opinion in Biotechnology 13, n.º 4 (agosto de 2002): 279–86. http://dx.doi.org/10.1016/s0958-1669(02)00342-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Halliwell, Catherine, Tony Cass, Jim Dunwell, LawrenceP Wackett, Steven Projan, Jeroen Hugenholtz, Michiel Kleerebezem, NicholasJ Turner e RobertE Speight. "Biotechnology". Current Opinion in Biotechnology 13, n.º 5 (outubro de 2002): 407–11. http://dx.doi.org/10.1016/s0958-1669(02)00371-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz, Michiel Kleerebezem e Andrew J. Daugulis. "Biotechnology". Current Opinion in Biotechnology 10, n.º 6 (dezembro de 1999): 517–22. http://dx.doi.org/10.1016/s0958-1669(99)00021-x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

CASS, T., J. DUNWELL, L. WHACKETT, G. GILARDI, T. KOST, P. CONDREAY e D. POMPLIANO. "Biotechnology". Current Opinion in Biotechnology 10, n.º 2 (1 de abril de 1999): 105–11. http://dx.doi.org/10.1016/s0958-1669(99)80018-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Hecht, Hans-Jürgen, e Dieter Strack. "Biotechnology". Phytochemistry 53, n.º 5 (março de 2000): 620. http://dx.doi.org/10.1016/s0031-9422(99)00588-9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Varela, Justo Corti. "Biotechnology". European Journal of Risk Regulation 1, n.º 1 (março de 2010): 63–71. http://dx.doi.org/10.1017/s1867299x00000076.

Texto completo da fonte

Resumo:

This section aims to update readers on decisions related to marketing products of modern biotechnology (e.g., GMOs, animal clones) at EU level and on national measures concerning their production. Special attention is devoted to problems of competence between Member States and the EU in regulating biotechnology issues; the institutional dynamics of decision making regarding products derived from modern biotechnology; the relationship between the EFSA and the EU institutions on green biotech-related issues; the evolution of EU regulatory framework and of national attitudes towards the risks and benefits of biotechnology derived products and their production. This section will also delve into the interaction between the EU legislation and WTO law regarding advances in the application of biotechnology within the agri-food value chain.

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Mereu, Claudio. "Biotechnology". European Journal of Risk Regulation 2, n.º 4 (dezembro de 2011): 553–56. http://dx.doi.org/10.1017/s1867299x00001598.

Texto completo da fonte

Resumo:

Regulation n. 1107/2009 of the European Parliament and Council of 21 October 2009 concerning the placing of plant protection products on the market entered into force on 14 December 2009 and applies as of 14 June 2011, subject to some transitional measures set out in Article 80. It shall replace gradually the current legislation on plant protection products which is laid down in Council Directive 91/414/EEC and related implementing Regulations.Broadly speaking, the harmonized authorization system for active substances used in plant protection products, as originally set out in Directive 91/414/ EEC, is maintained. Indeed, the placing on the market of plant protection products is still subject to a two-steps process whereby active substances are approved at the EU-level (with the inclusion into a “positive list” – Annex I to the new Regulation) while formulated products are authorised at the national level based on “Uniform Principles” laid down in a new implementing Regulation 546/2011. However, the criteria underlying each of these two steps have changed remarkably.

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

GREGER, J. L. "Biotechnology". Journal of the American Dietetic Association 100, n.º 11 (novembro de 2000): 1306–8. http://dx.doi.org/10.1016/s0002-8223(00)00370-9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Leigh, Ron. "Biotechnology". Transactions of the Institute of Measurement and Control 19, n.º 5 (dezembro de 1997): 222. http://dx.doi.org/10.1177/014233129701900501.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Bruhn, Christine M. "BIOTECHNOLOGY". Nutrition Today 33, n.º 1 (janeiro de 1998): 13–18. http://dx.doi.org/10.1097/00017285-199801000-00004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Lesch, William C., Cheryl J. Wachenheim e Bard S. Stillerad. "Biotechnology". Health Marketing Quarterly 22, n.º 3 (1 de janeiro de 2005): 59–81. http://dx.doi.org/10.1300/j026v22n03_05.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Byford, G. H. "Biotechnology". Journal of Biomedical Engineering 10, n.º 1 (janeiro de 1988): 3. http://dx.doi.org/10.1016/0141-5425(88)90019-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Abrams, Fredrick R. "Biotechnology". JAMA 289, n.º 4 (22 de janeiro de 2003): 488. http://dx.doi.org/10.1001/jama.289.4.488.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

White, William E. "Biotechnology". Applied Biochemistry and Biotechnology 15, n.º 1 (junho de 1987): 81–83. http://dx.doi.org/10.1007/bf02798507.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Oniang'o, Ruth. "Biotechnology". African Journal of Food, Agriculture, Nutrition and Development 9, n.º 4 (25 de junho de 2009): 1. http://dx.doi.org/10.18697/ajfand.25.ed018.

Texto completo da fonte

Resumo:

The current issue of AJFAND covers a wide range of issues and also has a commentary on biotechnology by a world renown bio-philosopher, Prof Paul Thompson of the University of Toronto. Prof Thompson and I have known each other for close to a decade and have exchanged views on this issue to great length. Further, I have made arrangements for him to give lectures at the University of Nairobi and at Masinde Muliro University in Kenya.

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Oniang'o, Ruth. "Biotechnology". African Journal of Food, Agriculture, Nutrition and Development 6, n.º 1 (29 de abril de 2006): 1. http://dx.doi.org/10.18697/ajfand.10.ed003.

Texto completo da fonte

Resumo:

As we go to press, the World Trade Organization (WTO) has ruled in favor of a case that was pending before it against the EU for enforcing rules that were unfavorable to genetically modified foods or associated products from the United States of America .

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Miot, Sylvie, e Jean-Louis Boulay. "Pharmaceutical biotechnology, Chemical biotechnology: Web alert". Current Opinion in Biotechnology 13, n.º 6 (dezembro de 2002): 531–32. http://dx.doi.org/10.1016/s0958-1669(02)00383-x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Redaktion, TATuP. "Biotechnology ethics and public perceptions of biotechnology". TATuP - Zeitschrift für Technikfolgenabschätzung in Theorie und Praxis 9, n.º 4 (1 de dezembro de 2000): 149. http://dx.doi.org/10.14512/tatup.9.4.149.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!